Skip to main content
25 October 2019
WHO/BS/2019.2356 WHO 1st IS for Darbepoetin, for bioassay
WHO/BS/2019.2356 WHO 1st IS for Darbepoetin, for bioassay
25 October 2019
WHO/BS/2019.2357 WHO 3rd IS for Prekallikrein Activator
WHO/BS/2019.2357 WHO 3rd IS for Prekallikrein Activator
25 October 2019
WHO/BS/2019.2358 WHO 6th IS for HCV RNA for NAT
WHO/BS/2019.2358 WHO 6th IS for HCV RNA for NAT
25 October 2019
WHO/BS/2019.2359 WHO collaborative study to investigate the utility of next generation sequencing (NGS) as a molecular test of virus stocks used in the manufacture of Poliovirus vaccine (Oral)
WHO/BS/2019.2359 WHO collaborative study to investigate the utility of next generation sequencing (NGS) as a molecular test of virus stocks used in the manufacture of Poliovirus vaccine (Oral)
25 October 2019
WHO/BS/2019.2360 WHO ISs for HPV DNA for Low-Risk Types 6 & 11 and High-Risk Types 31, 33, 45, 52 and 58
WHO/BS/2019.2360 WHO ISs for HPV DNA for Low-Risk Types 6 & 11 and High-Risk Types 31, 33, 45, 52 and 58
25 October 2019
WHO/BS/2019.2362 WHO 1st IS for Enterovirus A71 inactivated vaccine
WHO/BS/2019.2362 WHO 1st IS for Enterovirus A71 inactivated vaccine
25 October 2019
WHO/BS/2019.2363 WHO IS for Mullerian Inhibiting Substance/Anti-Mullerian Hormone, human, recombinant
WHO/BS/2019.2363 WHO IS for Mullerian Inhibiting Substance/Anti-Mullerian Hormone, human, recombinant
25 October 2019
WHO/BS/2019.2364 WHO 4th IS for Streptokinase (16/358)
WHO/BS/2019.2364 WHO 4th IS for Streptokinase (16/358)
25 October 2019
WHO/BS/2019.2365 WHO 1st IS for Adalimumab
WHO/BS/2019.2365 WHO 1st IS for Adalimumab
25 October 2019
WHO/BS/2019.2366 WHO 1st IS for Insulin, human
WHO/BS/2019.2366 WHO 1st IS for Insulin, human
25 October 2019
WHO/BS/2019.2366 Appendix 1a - Phase 1 study protocol: 1st WHO IS for Insulin, Human
WHO/BS/2019.2366 Appendix 1a - Phase 1 study protocol: 1st WHO IS for Insulin, Human
25 October 2019
WHO/BS/2019.2367 WHO IS for Tetanus immunoglobulin (human)
WHO/BS/2019.2367 WHO IS for Tetanus immunoglobulin (human)
25 October 2019
WHO/BS/2019.2368 Collaborative Study to evaluate the proposed WHO 1st IS for Cancer Genomes
WHO/BS/2019.2368 Collaborative Study to evaluate the proposed WHO 1st IS for Cancer Genomes
25 October 2019
WHO/BS/2019.2369 WHO replacement IS for Tetanus Toxoid for use in Flocculation Test
WHO/BS/2019.2369 WHO replacement IS for Tetanus Toxoid for use in Flocculation Test
25 October 2019
WHO/BS/2019.2370 Collaborative Study to additionally assign value for Total Factor XIII-B Subunit Antigen to the WHO 1st IS for Factor XIII Plasma
WHO/BS/2019.2370 Collaborative Study to additionally assign value for Total Factor XIII-B Subunit Antigen to the WHO 1st IS for Factor XIII Plasma
25 October 2019
WHO/BS/2019.2371 WHO IRRs for Blood Group Genotyping
WHO/BS/2019.2371 WHO IRRs for Blood Group Genotyping
25 October 2019
WHO/BS/2019.2372 WHO 1st IS for antiserum to RSV
WHO/BS/2019.2372 WHO 1st IS for antiserum to RSV
25 October 2019
WHO/BS/2019.2373 Proposed WHO 1st Inter Reference Panel (19/158) for Quantitation of Lentiviral Vector Integration Copy Numbers
WHO/BS/2019.2373 Proposed WHO 1st Inter Reference Panel (19/158) for Quantitation of Lentiviral Vector Integration Copy Numbers
25 October 2019
WHO/BS/2019.2374 Evaluation of Candidate International Standards for Meningoccal Capsular Group W and Y Polysaccharides
WHO/BS/2019.2374 Evaluation of Candidate International Standards for Meningoccal Capsular Group W and Y Polysaccharides
25 October 2019
WHO/BS/2019.2375 Collaborative Study for the Establishment of the Third IS for Amphotericin B
WHO/BS/2019.2375 Collaborative Study for the Establishment of the Third IS for Amphotericin B
25 October 2019
WHO/BS/2019.2376 Collaborative Study to assess the suitability of the candidate WHO IRR for MSC identity (for flow cytometry) for advance therapies
WHO/BS/2019.2376 Collaborative Study to assess the suitability of the candidate WHO IRR for MSC identity (for flow cytometry) for advance therapies
25 October 2019
WHO/BS/2019.2377 Collaborative Study for 1st WHO Repository of Red Blood Cell Transfusion-Relevant Bacterial Reference Strains
WHO/BS/2019.2377 Collaborative Study for 1st WHO Repository of Red Blood Cell Transfusion-Relevant Bacterial Reference Strains
25 October 2019
WHO/BS/2019.2378 - New Projects for Endorsement
WHO/BS/2019.2378 - New Projects for Endorsement
